Recent Submissions
Omalizumab, the innovative biologic that disrupted the market of the treatment of allergic diseases
Characterization of potential therapeutic targets in Leishmania infantum
Sistemas de cloranfenicol y polivinilpirrolidona para aplicación tópica
Development of G9a-targeted BioPROTACs based on peptides and nanobodies
Empleo de endolisinas frente a Gram-negativos